[Apoptosis-inducing effect of C-MYC siRNA on acute lymphoblastic leukemia Jurkat cell line]

Ting-Bo Liu1, Xiao-Feng Luo, Jian-Da Hu

  • 1Fujian Institut of Hematology, Fujian Medical University Union Hospital, Fujian Province, China. liutb@medmail.com.cn

Insights

Chemically synthesized C-MYC siRNA significantly inhibits acute lymphoblastic Jurkat cell proliferation and induces apoptosis. This targeted approach offers potential for controlling cancer cell growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Context:

  • Acute lymphoblastic leukemia (ALL) is a significant hematological malignancy.
  • The c-MYC oncogene plays a crucial role in cell proliferation and apoptosis.
  • Targeting c-MYC offers a potential therapeutic strategy for ALL.

Purpose:

  • To investigate the effects of C-MYC siRNA on the proliferation and apoptosis of the Jurkat cell line.
  • To assess the efficacy of chemically synthesized C-MYC siRNA in inhibiting cancer cell growth.
  • To analyze the impact of C-MYC siRNA on Jurkat cell apoptosis.

Summary:

  • C-MYC siRNA was designed, synthesized, and transfected into Jurkat cells.
  • Cell proliferation was assessed using MTS assays and colony formation tests.
  • Apoptosis was evaluated via flow cytometry and TUNEL assays.
  • Results demonstrated dose-dependent inhibition of proliferation and increased apoptosis with C-MYC siRNA treatment.

Impact:

  • C-MYC siRNA effectively inhibits Jurkat cell proliferation.
  • C-MYC siRNA induces significant apoptosis in Jurkat cells.
  • This study validates C-MYC siRNA as a potential therapeutic agent for acute lymphoblastic leukemia.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...